Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,441 | -9,955 | -11,718 | -4,920 | -3,798 |
| Depreciation Amortization | 142 | 150 | 183 | 304 | 461 |
| Income taxes - deferred | 62 | 62 | 62 | 196 | 0 |
| Accounts receivable | -1,067 | 3,219 | 2,920 | 899 | 1,008 |
| Accounts payable and accrued liabilities | 130 | -737 | -569 | 252 | -1,683 |
| Other Working Capital | -505 | 45 | 2,367 | 1,967 | 929 |
| Other Operating Activity | 1,464 | -1,257 | -412 | -1,019 | -4,727 |
| Operating Cash Flow | $-3,216 | $-8,474 | $-7,168 | $-2,323 | $-7,809 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -79 | -84 | -81 | 67 | 1,688 |
| Investing Cash Flow | $-79 | $-84 | $-81 | $67 | $1,688 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1,331 | N/A |
| Debt Issued | N/A | N/A | N/A | 2,500 | N/A |
| Debt Repayment | -750 | -1,000 | -750 | N/A | N/A |
| Common Stock Issued | 973 | 18,825 | 6,019 | 39 | 5,856 |
| Other Financing Activity | 0 | -1,092 | -239 | -149 | -74 |
| Financing Cash Flow | $223 | $16,734 | $5,030 | $3,720 | $5,781 |
| Exchange Rate Effect | -2 | -13 | -1 | 0 | -209 |
| Beginning Cash Position | 18,643 | 10,481 | 12,702 | 11,237 | 11,785 |
| End Cash Position | 15,570 | 18,643 | 10,481 | 12,702 | 11,237 |
| Net Cash Flow | $-3,074 | $8,162 | $-2,221 | $1,465 | $-549 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,216 | -8,474 | -7,168 | -2,323 | -7,809 |
| Capital Expenditure | -87 | -92 | -85 | N/A | -71 |
| Free Cash Flow | -3,303 | -8,566 | -7,253 | -2,323 | -7,880 |